IE00BQ70R696
IE00BQ70R696
Invesco NASDAQ Biotech UCITS ETF Acc
Loading chart...
About this ETF
The Invesco Nasdaq Biotech UCITS ETF seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
TER
0.4%
Total Expense Ratio per year
Fund Size
€432.81M
Assets under management
Holdings
246
Underlying equities
Dividend Yield
0%
Accumulating
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
18.06
Weighted Fwd P/E
59.17
💰 Revenue Estimates
Current Year CY
+34.79% ⌀ 18 Analysts Coverage
Next Year NY
+396.2% ⌀ 18 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
-305.44% ⌀ 16 Analysts Coverage
Next Year NY
+234.43% ⌀ 15 Analysts Coverage
Related ETFs
State Street® SPDR® S&P® U.S. Health Care Select Sector UCITS ETF (Acc)
53.03 USD
TER 0.15% 1Y +16.1%
Invesco Health Care S&P US Select Sector UCITS ETF Acc
846.1 USD
TER 0.14% 1Y +16.2%
ETF Profile
Provider
Fund Type
ETF Type
Passive Inception Date
11/06/2014 (11 yrs)
Index Group
NASDAQ Biotechnology Index
Nasdaq Biotechnology Region
-
Country
United States Sector
Health Care Strategy
-
Theme
Biotech Distribution Policy
Accumulating Replication
Swap-based Unfunded Sustainable
No 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
6/7 High
Diversification Score: 15/100 Low (Concentration Risk)
Diversification Score
15/100 Low (Concentration Risk)
5Y Volatility
21.2% p.a.
Max Drawdown (5Y)
-34.6%
Sharpe Ratio (5Y)
0.21
Beta Factor
0.81
Notes & Warnings
Fund Volume (AUM) Solid fund volume
🟡 Moderate analyst coverage (16.2 analysts)
🔴 Severe sector concentration risk: 100% in "Healthcare".
🔴 Extreme industry concentration: 68% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).